Public-Private Partnerships for Vaccine Research

Public-private partnerships (PPPs) have emerged as an effective model for vaccine research and development. These partnerships bring together the expertise and resources of both the public and private sectors to accelerate the development of vaccines and improve access to them. PPPs can help to bridge the funding gap for vaccine development, share risks and rewards, and ensure that vaccines are affordable and accessible to all. They also facilitate collaboration between industry, academia, and government, leading to innovation and discovery. The success of PPPs in vaccine development highlights the importance of collaboration and cooperation in achieving global health goals.

    Related Conference of Public-Private Partnerships for Vaccine Research

    November 19-20, 2025

    6th International Conference on Vaccine Research

    Tokyo, Japan
    December 22-23, 2025

    7th World Congress on Vaccine and Immunology

    Amsterdam, Netherlands
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain

    Public-Private Partnerships for Vaccine Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in